Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Recruiting · NCT06319560 · Interventional (participants receive a specific treatment) · Lead sponsor: National University of Malaysia
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
Who can take part
Inclusion criteria
- Singleton
- Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus
Exclusion criteria
- autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
- chronic kidney disease
- fetal anomaly
- women on steroid therapy
- diabetic retinopathy
- known thalassaemia or thalassaemia carrier
Where it is running
1 location listed.
- Antenatal clinic, UKM Medical Centre - Cheras, Kuala Lumpur, Malaysia